Loading... Please wait...
Sort by:
  • Pages:
  • 1
  • 2
  • 3
  • Medical Affairs Reputations: Asthma/COPD (EU5) 2017
    Learn More Medical Affairs Reputations: Asthma/COPD (EU5) 2017
    How well does your asthma/COPD medical affairs team performance compare with the rest? According to this latest survey of 150 pulmonologists and primary care physicians across the EU5 (UK, France, Germany, Italy and...
  • Medical Affairs Reputations:  Asthma/COPD (US) 2017
    Learn More Medical Affairs Reputations: Asthma/COPD (US) 2017
    How well does your asthma/COPD medical affairs team performance compare with the rest? According to this latest survey of 100 US pulmonologists and primary care physicians, the performance of asthma/COPD medical affairs...
  • MSL stakeholder engagement: meeting expectations
    Learn More MSL stakeholder engagement: meeting expectations
    MSL Stakeholder Engagement–Meeting Expectations In this report, FirstWord identifies practical solutions to the stakeholder engagement challenges faced by medical science liaisons (MSLs) teams in 2017. Discover...
  • Charting MSL Activity and Performance (2017)
    Learn More Charting MSL Activity and Performance (2017)
    A unique survey-based report providing key insights and actionable intelligence about MSL activity and performance. Charting MSL Activity and Performance (2017) distils key findings from one of the most comprehensive...
  • Medical Affairs in Orphan Drugs
    Learn More Medical Affairs in Orphan Drugs
    Orphan drugs: Is your medical affairs team leading the fray or lagging behind?  Traditional commercial models simply don’t work for orphan drugs, not least because the physician and patient populations are so...
  • The Future of Medical Affairs
    Learn More The Future of Medical Affairs
    What are the future opportunities and challenges for medical affairs? As the interface between companies and KOLs, HCPs, payers and patients, medical affairs has grown rapidly in importance.  And demands are set to...
  • The Real Value of Medical Affairs
    Learn More The Real Value of Medical Affairs
    How to push Medical Affairs to the next level of effectiveness   Are Medical Affairs (MA) teams doing enough to satisfy doctors? What specific improvements to information and interactions would elevate MA to...
  • Harnessing the Power of Big Data and Analytics in Medical Affairs
    Learn More Harnessing the Power of Big Data and Analytics in Medical Affairs
    Harness big data insights to improve medical affairs outcomes Medical affairs teams are uniquely placed to apply insights from big data in a range of areas from improving KOL engagement to generate persuasive real world...
  • New KOL Engagement: Building Relationships with the Digital KOL Generation
    Learn More New KOL Engagement: Building Relationships with the Digital KOL Generation
    New Digital KOLs are shaping medical opinion – how do you plan to engage them? Digital KOLs are the new kids on the block and making an impact. Tech savvy medical professionals with something to say are becoming...
  • MSL Metrics: Measuring Success
    Learn More MSL Metrics: Measuring Success
    How to effectively measure MSL performance How can you evaluate MSL activity to ensure effective outcomes? MSLs’ ability to harness KOL feedback provides unique insights to refine clinical, marketing and sales...
  • The Role of Medical Affairs in a Successful Commercial Launch
    Learn More The Role of Medical Affairs in a Successful Commercial Launch
    Drive greater product launch success by fully engaging the medical affairs department. Ensure maximum exposure and positive uptake of new therapies by harnessing their talents in scientific interpretation, evidence...
  • Harnessing the Power of Phase IV Observational Studies
    Learn More Harnessing the Power of Phase IV Observational Studies
    Phase IV studies: Pioneering approaches are re-engineering processes, timelines and costs  Phase IV is in a state of flux. New digital methods are on trial, there’s an explosion of data sources, and more...
  • Tomorrow’s MSLs
    Learn More Tomorrow’s MSLs
    Some experts believe the MSL is poised to become the face of the pharma industry. The primary role of the MSL is to establish and maintain trusted relationships with stakeholders and provide real value. It is this...
  • Innovations in Medical Communications and Information
    Learn More Innovations in Medical Communications and Information
    Today’s medical information and communications teams must look “outside the box” for cost-effective solutions to connecting with an increasingly diverse audience. This report will help you understand...
  • Medical Affairs Reputations (US): Multiple Sclerosis
    Learn More Medical Affairs Reputations (US): Multiple Sclerosis
    Compare how well pharma Medical Affairs teams perform and find out which ones physicians rate, in our exclusive report on the Multiple Sclerosis sector. See how well your team stacks up against the competition and where...
  • Medical Affairs Reputations (EU5): Multiple Sclerosis
    Learn More Medical Affairs Reputations (EU5): Multiple Sclerosis
    Compare how well pharma Medical Affairs teams perform and find out which ones physicians rate, in our exclusive report on the Multiple Sclerosis sector. See how well your team stacks up against the competition and where...
  • Pages:
  • 1
  • 2
  • 3

customer.service@firstwordpharma.com

All Contents Copyright © 2017 Doctor's Guide Publishing Limited All Rights Reserved